Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma
Auteurs principaux: | Croucher, P, Shipman, C, Perry, M, Lippitt, J, Asosingh, K, van Beek, E, Van Camp, B, Russell, R, Dunstan, C, Vanderkerken, K |
---|---|
Format: | Journal article |
Publié: |
2001
|
Documents similaires
-
Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma.
par: Croucher, P, et autres
Publié: (2001) -
Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2MM model of multiple myeloma.
par: Croucher, P, et autres
Publié: (2000) -
Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
par: Croucher, P, et autres
Publié: (2003) -
Zoledronic acid inhibits the development of osteolytic bone disease and increases disease free survival in a murine model of multiple myeloma.
par: Croucher, P, et autres
Publié: (2001) -
Osteoprotegerin and the development of myeloma bone disease
par: Croucher, P, et autres
Publié: (2004)